Integrated machine learning and molecular dynamics-driven multi-target virtual screening of FDA-approved drugs for drug repurposing in breast cancer.


Kırboğa K. K., Acar Ş., Şen M., Rudrapal M.

In silico pharmacology, cilt.14, sa.2, ss.171, 2026 (Hakemli Dergi)